ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2117

Algorithm Using Genome-Wide SNP Analysis for Prediction of Radiographic Progression Per Year in RA Patients From Multiple Medical Cohorts

Tsukasa Matsubara1, Satoru Koyano2, Yoshitada Sakai3, Keiko Funahashi2, James E. Middleton2, Takako Miura1, Kosuke Okuda1, Takeshi Nakamura1, Akira Sagawa4, Takeo Sakurai5, Hiroaki Matsuno6, Tomomaro Izumihara7 and Eisuke Shono8, 1Matsubara Mayflower Hospital, Kato, Japan, 2Research Institute of Joint Diseases, Kobe, Japan, 3Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 4Sagawa Akira Rheumatology Clinic, Sapporo, Japan, 5Inoue Hospital, Takasaki, Japan, 6Matsuno Clinic for Rheumatic Diseases, Toyama, Japan, 7Izumihara Rheumatic and Medical Clinic, Kagoshima, Japan, 8Shono Rheumatology Clinic, Fukuoka, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Joint destruction and polymorphism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects III: Infections/Risk Factors for Incident Rheumatoid Arthritis/Metrology/Classification/Biomarkers/Predictors of Rheumatolid Arthritis Activity & Severity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although not yet fully possible, ideally, since patients with rapidly progressing joint destruction need tight initial control, predicting the progression of joint destruction would be pivotal in establishing a treatment strategy for individual RA patients. We developed a SNP algorithm with the aim of enabling the prediction of yearly radiographic progression by means of genome-wide SNP analysis using multiple medical cohorts.

Methods: One-hundred twenty-four RA patients whose disease duration was 5 years or less were enrolled in this study from 6 hospitals in different regions of Japan. All patients were treated with biologics after the failure of DMARDs therapy. Radiographic progression of joint destruction was estimated by Sharp score per year of disease duration. We defined three groups, rapid, intermediate, and slow radiographic progression, according to Sharp score per year of disease duration. Twenty-three patients had a yearly Sharp score of >50 (rapid radiographic progression), 76 had a yearly score of 50-10 (intermediate radiographic progression) and 25 had a yearly score of <10 (slow radiographic progression). Case-control analyses between 278,347 SNPs and radiographic progression (rapid vs. intermediate+slow or rapid+intermediate vs. slow) were examined by Fisher’s exact test. We selected 10 SNPs closely associated with radiographic progression (p < 0.0001). We then scored a relationship between each SNP and radiographic progression, the estimated total score of the 10 SNPs (estimated scoring in each SNP was as follows: homo allele in the majority in rapid radiographic progression group: +1 point, hetero allele: 0 point, and homo allele in the majority of intermediate+slow radiographic progression group: -1 point), and examined relationships between the rapid and intermediate+slow group, and the total score.

Results: Accuracy ((true positive+true negative)/total), specificity (true negative/(false positive+true negative)) and sensitivity (true positive/(true positive+false negative)) of the algorithm for distinguishing the rapid progression group from the intermediate+slow progression group ranged from 93-96%. Accuracy, specificity and sensitivity of the algorithm for distinguishing the rapid+intermediate progression group from the slow progression group ranged from 88-90%. It is therefore suggested that this SNP algorithm may enable the prediction of rapidly progressing severe joint destruction.

Conclusion: This highly accurate algorithm using SNP analysis may be useful in initially diagnosing rapid radiographic progression, and, in this way, may contribute to establishing a strategy of treatment for individual RA patients.


Disclosure:

T. Matsubara,
None;

S. Koyano,
None;

Y. Sakai,
None;

K. Funahashi,
None;

J. E. Middleton,
None;

T. Miura,
None;

K. Okuda,
None;

T. Nakamura,
None;

A. Sagawa,
None;

T. Sakurai,
None;

H. Matsuno,
None;

T. Izumihara,
None;

E. Shono,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/algorithm-using-genome-wide-snp-analysis-for-prediction-of-radiographic-progression-per-year-in-ra-patients-from-multiple-medical-cohorts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology